Posters such as those presented by experts at Patheon are used at the CRS Annual Meeting & Exposition to display scientific achievements and the newest technologies
Patheon, the pharmaceutical services business, showcases the company’s fully integrated early development services at the 41st Annual Meeting & Exposition of the Controlled Release Society (CRS) in Chicago from 12-16 July.
Solomon Kirsh, Arasu Kondappan, Enrico Corona, Paul Sabo and Sateesh Sathigari represented Patheon in leading five out of the nearly 750 poster and podium presentations offered at the event. Posters such as those presented by experts at Patheon are used at the CRS Annual Meeting & Exposition to display scientific achievements and the newest technologies.
Solomon Kirsh, chemist at Patheon, presented a poster detailing rapid HPLC method supporting renin inhibitor enteric-coated beads formulation development; Arasu Kondappan, pharmaceutical formulation scientist, discussed the formulation of controlled release orally disintegrating tablets of water soluble compounds; and Enrico Corona, manager of formulation and process development, presented a poster on the development of the manufacturing process for a parenteral depot formulation in the situ precipitation.
Podium presentations included Stepwise Approach to Preformulation and Formulation Development to Maximize Clinical Success presented by Paul Sabo, senior specialist formulation at Patheon, and Production of Nano/Micro Drug Particles by Supercritical Fluid Technology led by Sateesh Sathigari, scientist of formulation and process development at Patheon.
The CRS Annual Meeting & Exposition is a professional, scientific meeting attended by more than 1,300 international scientists who work in drug delivery, consumer and diversified products. The theme of this year’s CRS Annual Meeting & Exposition was “Translation of Delivery Technology: Innovation to Commercialization,” and featured technology forums, soapbox sessions, industry roundtables and workshops where attendees could learn about pharmaceutical companies’ research, products and technology, and network with industry experts.